Investment Rating - The report gives an "Accumulate" rating for the company, indicating a positive outlook for its stock performance in the coming months [4][7][54]. Core Insights - The company is a leading player in the global commercial and passenger vehicle interior sector, with a strong product portfolio that includes seat headrests, armrests, central control systems, and interior components [1][13]. - The acquisition of Grammer AG has significantly expanded the company's business scale and product matrix, enhancing its R&D capabilities and global market presence [2][27]. - The strategic emerging business is entering a rapid growth phase, with over 20 orders for passenger vehicle seat assemblies and expected total sales exceeding 90 billion yuan [3][20]. Summary by Sections Company Overview - Founded in 1996, the company specializes in both passenger and commercial vehicle components, establishing a global production and marketing network with nearly 70 subsidiaries across 20 countries [1][13]. - The company has achieved significant recognition for its innovative designs and manufacturing processes, supplying major automotive brands worldwide [1][14]. Financial Performance - The company has shown stable revenue growth, with projected revenues of 22.86 billion yuan in 2024, 25.77 billion yuan in 2025, and 29.49 billion yuan in 2026, reflecting year-on-year growth rates of 5.99%, 12.69%, and 14.45% respectively [4][52]. - The net profit attributable to shareholders is expected to recover from a loss of 486.91 million yuan in 2024 to a profit of 847.48 million yuan in 2026, indicating a significant turnaround [4][52]. Business Segments - The traditional business segment, which includes headrests and armrests, is expected to see a slight decline in revenue due to market conditions, while the emerging business segment is projected to grow rapidly, with revenues reaching 31.50 billion yuan in 2024 and 102.63 billion yuan in 2026 [46][49]. - The Grammer division is anticipated to maintain stable growth, particularly in the Asia-Pacific region, benefiting from operational synergies post-acquisition [46][48]. Market Position and Outlook - The company is well-positioned to benefit from the trend of domestic automotive seat assembly localization and the development of intelligent cockpits, which are expected to drive future growth [4][54]. - The report emphasizes the company's competitive advantages in technology and R&D, which are crucial for maintaining its leading position in the industry [54].

Company Overview - Jinggong Technology (002006) is a leading enterprise in the carbon fiber equipment industry, focusing on high-end carbon fiber equipment and advanced composite materials [2] - The company was founded in 1992 and went public in 2004, with a market share of over 50% in the domestic carbon fiber production line market [13] - Jinggong Technology has expanded its business to include new energy equipment, intelligent construction machinery, intelligent textile machinery, and green resource recycling equipment [2][13] Industry Analysis - The carbon fiber industry is a strategic emerging industry in China, supported by favorable government policies [3] - From 2015 to 2022, China's carbon fiber demand grew at a CAGR of 23.71%, reaching 74,429 tons in 2022 [16] - Despite a 7.19% YoY decline in 2023, the carbon fiber market is expected to maintain rapid growth due to increasing applications in sports, wind power, aerospace, and other fields [16] Competitive Advantages - Jinggong Technology has established a strong competitive barrier through its independent R&D capabilities, cost control advantages, and one-stop technical service system [4] - The company has signed contracts worth over 4 billion yuan for carbon fiber equipment since 2020, with a CAGR of 52.14% in revenue from 2020 to 2023 [18] - Jinggong Technology has successfully expanded its international market, establishing partnerships with clients in South Korea, Vietnam, and Saudi Arabia [18] Financial Performance - Revenue for 2024-2026 is projected to be 1.695/1.916/2.211 billion yuan, with net profit attributable to shareholders of 243/312/397 million yuan [5] - The company's carbon fiber equipment business is expected to maintain a high gross margin of 40%-41% from 2024 to 2026 [34] - ROE is forecasted to increase from 10.01% in 2024 to 13.52% in 2026, indicating improving profitability [6] Investment Recommendation - Jinggong Technology is given an "Overweight" rating with a target price of 16.07 yuan [8] - The company's PE ratio is expected to decrease from 34x in 2024 to 21x in 2026, reflecting strong growth potential [5] - Compared to industry peers, Jinggong Technology has a higher valuation premium due to its leading position in the carbon fiber equipment market [38]

Investment Rating - The report maintains a "Recommended" rating for the healthcare sector, with a focus on innovation and overseas expansion [1] Core Views - The healthcare sector is at a triple bottom in terms of performance, valuation, and fund allocation, with 2023 performance significantly impacted by anti-corruption measures [3] - The payment side of the healthcare industry is expected to gradually improve, driven by the development of commercial health insurance [3] - Pharmaceutical innovation and overseas expansion are key growth areas, with companies strong in product and channel capabilities likely to gain a competitive edge [3] - Opportunities in mergers and acquisitions (M&A), centralized procurement clearance, and undervalued stocks are highlighted [3] Pharmaceutical Innovation - China's pharmaceutical innovation has entered a phase of commercialization, with significant progress in areas such as ADC, GLP-1, bispecific antibodies, and AD [4] - Domestic innovation drugs are increasingly being authorized and approved for overseas markets, showcasing the rapid improvement in innovation capabilities [4] - Companies with advanced R&D progress in large therapeutic areas are expected to perform well in 2025 [4] Overseas Expansion - Overseas expansion is a critical step for Chinese pharmaceutical companies to become global players, with developed markets offering higher prices and emerging markets providing growth potential [5] - Companies with strong product capabilities and channel management are expected to lead in overseas markets [5] M&A and Centralized Procurement - The China Securities Regulatory Commission has issued policies to encourage M&A, which is expected to accelerate industry consolidation [8] - Centralized procurement has been implemented in various sectors, with some areas already seeing the impact of price reductions, such as insulin and orthopedic products [8] - Undervalued sectors with improving fundamentals are expected to benefit from events like the National Essential Drug List and state-owned enterprise reforms [8] Sector Performance and Valuation - The healthcare sector underperformed the CSI 300 index in 2024, with chemical drugs and traditional Chinese medicine outperforming other sub-sectors [14][16] - The sector's valuation remains at historically low levels, with a slight rebound in the fourth quarter of 2024 [17][23] - The price-to-earnings (PE) ratio of the healthcare sector is at its lowest in 15 years, around 25 times [26] Industry Fundamentals - The healthcare sector's revenue growth stabilized in 2024, with a year-on-year decline of 0.07% in the first three quarters, while net profit attributable to shareholders fell by 7.28% [27] - Fund allocation to the healthcare sector is at a five-year low, with only 10.17% of the total market fund allocation [31] Payment Side Improvement - The balance rate of China's urban employee medical insurance fund has been declining, reaching 16.91% in the first ten months of 2024 [36] - Policies encouraging commercial health insurance are expected to alleviate payment pressure, with commercial health insurance premiums reaching 900 billion yuan in 2023 [45] Innovation Drug Development - China has become the second-largest country globally in terms of core clinical trials for innovative drugs, with 322 trials conducted in 2022 [72] - The proportion of domestic innovative drugs in the market is expected to increase significantly, with a projected share of 47.13% by 2025 and 57.55% by 2030 [65] Overseas Market Potential - The global pharmaceutical market is projected to grow to $20.9 trillion by 2030, with China's market expected to reach $3.9 trillion, maintaining a 17% share of the global market [99] - Overseas markets, particularly in developed countries, offer higher drug prices, with China's drug prices being only about 10% of those in the US [103] M&A Opportunities - The healthcare sector is expected to see increased M&A activity, with policies encouraging industry consolidation and the acquisition of high-quality assets [121] - A notable example is China Biologic Products' acquisition of a majority stake in Hybio Pharmaceutical, which has led to a significant increase in Hybio's stock price [123] Centralized Procurement Impact - Centralized procurement has led to significant price reductions in sectors such as blood dialysis and insulin, with some products seeing price drops of up to 74% [127][135] - The impact of centralized procurement is gradually being absorbed, with sectors like orthopedics expected to enter a new growth phase [136]

Industry Investment Rating - The report maintains a "Recommend" rating for the media and internet industry [7] Core Views - The media industry (Shenwan) fell by 5.84% in December 2024, ranking 27th among sub-industries, while the CSI 300 rose by 0.47% and the Shanghai Composite Index rose by 0.76% [1] - The AI sector is a key investment focus, with significant model iterations and application-side prosperity expected to drive valuation and performance improvements in the media sector [5] - The gaming market in China reached a total size of 325.78 billion yuan in 2024, with mobile games accounting for 238.22 billion yuan, a year-on-year increase of 7.53% and 5.01% respectively [3] - The domestic box office in 2024 was 42.5 billion yuan, a year-on-year decline of 22.61%, with the top five films contributing significantly to the box office, four of which were released during the Spring Festival period [4] Market Performance - In December 2024, the media industry (Shenwan) fell by 5.84%, with the gaming II sector experiencing the largest decline of 7.18%, while the publishing sector had the smallest decline of 2.99% [18] - The AI index (884201.WI) fell by 1.66% in December 2024, underperforming the CSI 300 by 2.13 percentage points, but it has outperformed the CSI 300 by 3.80 percentage points year-to-date [25] AI Sector Developments - OpenAI launched the o3 model, completing its 12-day product release event, which included the full version of o1 and the Sora model [2] - Other significant AI developments include Meta's Llama 3.3, Google's Imagen 3 and Veo 2 models, and domestic models like Tencent's Hunyuan and Kimi's k1 model [2][30][31] - CES 2025 saw NVIDIA's CEO Jensen Huang announce the RTX 5090 D GPU and the Cosmos world foundational model platform [2] Gaming Sector - In 2024, 1,306 domestic game licenses and 110 imported game licenses were issued, with 122 domestic and 13 imported licenses issued in December alone [77] - Key game companies like Tencent, NetEase, and Perfect World have new games scheduled for release in early 2025, which are expected to boost the gaming market [3][72] - The mobile game market saw significant growth, with games like "Honor of Kings" and "PUBG Mobile" maintaining strong performance [44][48] Film Sector - The top five films in 2024 accounted for a significant portion of the box office, with "YOLO" leading at 3.42 billion yuan, followed by "Pegasus 2" and "Article 20" [4][99] - The Spring Festival 2025 lineup includes highly anticipated films like "Detective Chinatown 1900" and "The Legend of the Condor Heroes: The Great Hero," which are expected to drive box office performance [100][101] Investment Recommendations - The report recommends focusing on AI-driven investments, particularly in gaming companies with strong product pipelines like恺英网络, 神州泰岳, and 完美世界 [5] - The publishing sector is highlighted for its stable cash flow and high dividends, with companies like 南方传媒 and 皖新传媒 recommended for attention [5] - In the film and IP sector, companies like 芒果超媒, 光线传媒, and 上海电影 are recommended due to their potential for AI-driven IP revaluation [5]

Investment Rating - The report maintains a "Buy" rating for the company, indicating an expected stock price increase of over 15% compared to the benchmark index [6]. Core Insights - The company is projected to achieve a revenue of between 3.8 billion to 4 billion CNY in 2024, representing a year-on-year growth of 16.88% to 23.03%. The net profit attributable to shareholders is expected to be between 620 million to 680 million CNY, showing a significant increase of 245.92% to 279.39% [1]. - The digital maintenance business continues to lead the industry, with expected revenue of approximately 2.95 billion to 3.09 billion CNY in 2024. The digital energy business is also expanding, with projected revenue of around 830 million to 890 million CNY [2]. - The company is exploring new growth areas in integrated air-ground solutions, leveraging generative AI technology for smarter and more efficient inspection operations in energy and transportation sectors [3]. - The company focuses on R&D, production, sales, and services related to new energy charging piles, automotive diagnostics, and electronic components, indicating a broad future growth potential [4]. Financial Projections - The adjusted revenue forecasts for 2024-2026 are 3.91 billion, 4.62 billion, and 5.36 billion CNY, respectively. The net profit forecasts for the same period are 641.56 million, 706.20 million, and 827.92 million CNY, with corresponding EPS of 1.42, 1.56, and 1.83 CNY per share [4][8]. - The company’s revenue growth rates are projected at 20.36% for 2024, 18.12% for 2025, and 15.90% for 2026, with net profit growth rates of 257.95%, 10.07%, and 17.24% for the same years [10].

[Table_Main] 行业研究|可选消费 证券研究报告 可选消费行业点评报告 2025 年 01 月 08 日 [Table_Title] 微信蓝包打开消费新场景，关注节日催化 ——新消费行业点评报告 [Table_Summary] 事件： 微信官方 2024 年 12 月 17 日公告，微信小店目前正在灰度"送礼物" 功能。开年以来，微信小店运营团队先后公布 2025 年私域激励计划 和达人带货成长激励政策，并持续对送礼功能做出优化。 点评： 微信小店依托微信全域流量优势，具备丰富用户触点和转化机会 微信小店是微信平台向商家提供的商品信息展示、商品交易等功能的 技术服务。2024 年 8 月腾讯宣布将原先依托短视频公域流量的视频 号小店升级为微信小店，并在 24Q3 财报中首次将微信小店列为重点 业务之一。与视频号小店相比，微信小店串联起更多私域场景，支持 店铺及商品信息在公众平台账号（公众号、服务号）、视频号（直 播、短视频）、小程序、搜一搜等多个微信场景内流转，助力商家深 入挖掘用户消费场景，同时在开店门槛和入驻要求方面也有所放宽。 根据腾讯 24Q3 财报，微信及 Wechat 合并平均 MAU ...

[Table_Main] 行业研究|信息技术|技术硬件与设备 证券研究报告 技术硬件与设备行业策略报告 2025 年 1 月 6 日 [Table_Title] 他石琢己玉，AI 新机遇 ——通信行业 2025 年年度策略 [Table_Summary] 报告要点： 2024 年通信行业涨幅靠前，AI 是核心演绎方向 申万通信板块业绩呈强韧性。2024 年前三季度营业收入与归母分别 实现同比 3.58%/8.23%的正增长。2024 年，申万通信在 31 个一级行 业指数中位列第三。AI 是核心演绎方向，光模块、IDC、物联网等细 分板块涨幅居前。2024 年第三季度主动权益型公募同比增持、环比减 持。AI 及运营商是主要持仓方向。 关注主线趋势中边际改善方向，自主可控仍是核心 算力：模型的能力持续提升，促进 AI 商业闭环节奏提速的预期持续深 化。思维链及强化学习的引入，通过 Post-training 及 Inference 阶段 的 scaling，在极大缓解了 scaling law 的边际效用递减的情况，同时 相同参数的模型所需的训练及推理算力成倍增长，算力的基础硬件需 求高速扩张。光模块及 PCB ...

[Table_Main] 行业研究|电信服务 证券研究报告 电信服务行业周报 2025 年 01 月 06 日 [Table_Title] GB300 服务器或于 Q2 发布，兼顾端侧及基础硬件 ——通信行业周报 [Table_Summary] 报告要点： 市场整体行情及通信细分板块行情回顾 周行情：本周（2024.12.30-2025.01.03）上证综指回调 5.55%，深 证成指回调7.16%，创业板回调8.57%。本周申万通信回调 9.95%。 考虑通信行业的高景气度延续，AI、5.5G 及卫星通信持续推动行业 发展，我们给予通信及电子行业"推荐"评级。 细分行业：本周（2024.12.30-2025.01.03）通信板块三级子行业 中，通信终端及配件回调幅度最低，跌幅为 10.96%，其他通信设备 回调幅度最高，跌幅为 12.73%，本周各细分板块主要呈回调趋势。 个股方面：本周（2024.12.30-2025.01.03）通信板块上涨、下跌和 走平的个股数量占比分别为 7.87%、89.76%和 2.36%。其中，涨幅板 块分析方面，欣天科技（35.21%）、*ST 通脉（21.48%）、*ST ...

行业研究|可选消费|汽车与汽车零部件 证券研究报告 2025 年 01 月 06 日 汽车与汽车零部件行业 周报、月报 [Table_Title] 车企优惠、商用车与智能化 [Table_Summary] 报告要点： 政策空窗期下，企业端优惠再起，但整体力度未显著强于去年 12 月底 1 月初，受 2024 年"以旧换新"政策截止，但 2025 年新政策尚 未公布影响，车企端为稳定消费，纷纷推出各类优惠政策。如理想汽车 推出 1 月 1 日-31 日订车，若期间内无置换补贴政策，则理想汽车给与 15000 元/台的现金补贴。此外蔚来、零跑汽车、比亚迪、岚图、极氪、 极狐、东风本田、别克等均推出类似弥补政府补贴空窗期的企业优惠补 贴。长安深蓝、启源、阿维塔、小鹏、荣威、智己、五菱、特斯拉等则通 过直接优惠的方式吸引消费者。整体对比看，部分新势力的优惠或补贴 幅度优于去年，传统车企的优惠力度比去年的力度仍有不足。车企端优 惠能够一定程度提振政策空窗期的消费信心。 商用车销量显著提升与红利股趋势共振，但上游排产改善仍需观察 2024 年 12 月重卡销量 7.9 万台，环比增长 15%，同比增长 52%，高于 20 ...

Investment Rating - The report maintains a "Buy" rating for the industrial sector, specifically highlighting the mechanical equipment industry as a focus area for investment opportunities [1]. Core Insights - The report emphasizes the potential for mass production of humanoid robots, particularly from Tesla, which is expected to lead the market. It suggests monitoring the supply chain and key component suppliers involved in this sector [2]. - The report identifies significant investment opportunities in core components for humanoid robots, including actuators, sensors, and motors, as various manufacturers begin small-scale deliveries and trials [2]. - The low-altitude economy is highlighted as a burgeoning sector with vast market potential, driven by supportive policies and technological advancements in eVTOL (electric Vertical Take-Off and Landing) vehicles [3]. Summary by Sections Humanoid Robots - Tesla's humanoid robot, Optimus, is expected to achieve mass production by 2025, with a projected price point below $20,000, opening up substantial market opportunities [2][77]. - Domestic and international manufacturers are beginning to deliver demo units, focusing on hardware and performance, with companies like Unitree and Ubiquity Robotics leading the charge [2][80]. - Key components for humanoid robots include six-dimensional force sensors, with companies like Donghua Testing and Keli Sensor recommended for investment [2][76]. Export Chain - The report forecasts a stable export value for China, with a total export value of 23.04 trillion yuan in the first eleven months of 2024, reflecting a year-on-year growth of 6.7% [12]. - The export chain is viewed as a semi-cyclical and semi-consumption/growth sector, with specific companies showing clear layout opportunities despite trade policy disruptions [12]. Low-altitude Economy - The low-altitude economy is positioned as a new growth engine, with various provinces and cities actively developing supportive policies [42]. - The report anticipates a trillion-level market space for the low-altitude economy, with eVTOL vehicles expected to play a crucial role in its development [42]. - Companies such as EHang and WanFeng Aviation are highlighted as key players in the eVTOL market, with significant advancements expected in the coming years [42].